» Articles » PMID: 24436617

Prevalence and Predictors of Left Ventricular Diastolic Dysfunction in a Hispanic Patient Population

Overview
Journal Int J Angiol
Date 2014 Jan 18
PMID 24436617
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Minimal data exist on attributes of diastolic dysfunction in the Hispanic population. The purpose of this study was to evaluate the prevalence and predictors of diastolic dysfunction in a Hispanic patient population. We performed a retrospective review of 166 consecutive echocardiograms in a southwestern Texas Hospital that caters to a large Hispanic patient population. We identified all echocardiograms that met criteria for diastolic dysfunction and assessed baseline demographics and comorbidities in the cohort of Hispanic patients. A multivariate analysis was performed to identify the independent predictors of diastolic dysfunction. A total of 129 out of 166 patients (77.8%) were of Hispanic origin. Out of the 129 patients, 87 (67.4%) had some degree of diastolic dysfunction in this population suggesting a high prevalence in the study cohort. In the diastolic dysfunction group, the mean age was 64.5 ± 13.9, 37% were male and 63% female, 78% had diabetes, 85% had hypertension, and 49% had some degree of renal insufficiency (stages 3-5). A logistic multivariate analysis showed that diabetes was an independent predictor of diastolic dysfunction with odds ratio of 2.69 (95% confidence interval [CI], 1.06-6.28; p = 0.038). Similarly age (per year increase) and chronic kidney disease were independent predictors of diastolic dysfunction. We demonstrated that older age, presence of diabetes, and renal dysfunction are independent predictors of diastolic dysfunction in the Hispanic patient population. Strategies geared toward reducing diabetes and preventing renal dysfunction are likely to decrease prevalence of diastolic dysfunction and heart failure in this community.

Citing Articles

Predictors of adverse diastolic remodeling in non-diabetic patients presenting with ST-elevation myocardial infarction.

Al Ali L, Groot H, Assa S, Lipsic E, Hummel Y, Van Veldhuisen D BMC Cardiovasc Disord. 2023; 23(1):44.

PMID: 36690932 PMC: 9872414. DOI: 10.1186/s12872-023-03064-7.


Burden of Systolic and Diastolic Left Ventricular Dysfunction Among Hispanics in the United States: Insights From the Echocardiographic Study of Latinos.

Mehta H, Armstrong A, Swett K, Shah S, Allison M, Hurwitz B Circ Heart Fail. 2016; 9(4):e002733.

PMID: 27048764 PMC: 4826756. DOI: 10.1161/CIRCHEARTFAILURE.115.002733.

References
1.
von Bibra H, Hansen A, Dounis V, Bystedt T, Malmberg K, Ryden L . Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes. Heart. 2004; 90(12):1483-4. PMC: 1768602. DOI: 10.1136/hrt.2003.020842. View

2.
Stork T, Mockel M, Danne O, Voller H, Eichstadt H, Frei U . Left ventricular hypertrophy and diastolic dysfunction: their relation to coronary heart disease. Cardiovasc Drugs Ther. 1995; 9 Suppl 3:533-7. DOI: 10.1007/BF00877866. View

3.
Poulsen M, Henriksen J, Dahl J, Johansen A, Gerke O, Vach W . Left ventricular diastolic function in type 2 diabetes mellitus: prevalence and association with myocardial and vascular disease. Circ Cardiovasc Imaging. 2009; 3(1):24-31. DOI: 10.1161/CIRCIMAGING.109.855510. View

4.
Kane G, Karon B, Mahoney D, Redfield M, Roger V, Burnett Jr J . Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA. 2011; 306(8):856-63. PMC: 3269764. DOI: 10.1001/jama.2011.1201. View

5.
Aurigemma G, Gaasch W . Clinical practice. Diastolic heart failure. N Engl J Med. 2004; 351(11):1097-105. DOI: 10.1056/NEJMcp022709. View